Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in: Pediatric Rheumatology 1/2020

Open Access 01-12-2020 | Interstitial Nephritis | Case Report

Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature

Authors: Jingya Zhao, Qin Chen, Yunyun Zhu, Meng Zhao, Jun Liu, Zhenzhong Zhang, Xiaoting Gong

Published in: Pediatric Rheumatology | Issue 1/2020

Login to get access

Abstract

Background

Sjögren syndrome (SS) is a rare disease in pediatrics, and little attention has been paid to the clinical feature in these patients. To date, there are few cases concern about neurological and nephrological disorders in childhood Sjögren syndrome. We describe a case of Sjögren syndrome in a 12-year-old girl who developed neurological disorders and interstitial nephritis and review the literature currently available on this topic.

Case presentation

A 12-year-old girl was admitted to our hospital for arthritis and glucosuria. She was required to do labial gland and renal biopsy, because the positive for anti-nuclear antibody and anti-Sjögren syndrome B (anti-SSB) antibody. Then the biopsy was performed revealing the lymphocytic infiltrate in the small area and renal tubular interstitial damage,thus the diagnosis of Sjögren syndrome with tubular interstitial damage was made. Three months later, she presented again with headache, fever, nausea, vomiting and was recovered without drug therapy. Based on the patient’s medical history, laboratory and imaging examination, and treatment, we speculate that the disorders of the nervous system were caused by the Sjögren syndrome. The girl has stable renal function and no residual nervous system damage in the next 1.5 years, but she underwent low dose prednisone therapy because of persistent renal glucosuria.

Conclusions

Nephrological disorders and neurological involvement are rare manifestations of Sjögren syndrome in children, and rarely presented as the initial symptoms. It should be suspected in children presenting with unexplained renal diseases, neurological abnormalities, or unexplained fever. Although there is no guidelines on the diagnosis and treatment of children Sjögren syndrome are currently available, early recognition and the appropriate treatment of renal damage and neurologic involvement would improve prognosis and prevent complications.
Literature
1.
Ienopoli S, Carsons SE. Extraglandular manifestations of primary Sjogren’s syndrome. Oral Maxillofac Surg Clin North Am. 2014;26:91–9.PubMedCrossRef
2.
Matsui Y, Takenouchi T, Narabayashi A, Ohara K, Nakahara T, Takahashi T. Childhood Sjogren syndrome presenting as acute brainstem encephalitis. Brain Dev. 2016;38:158–62.PubMedCrossRef
3.
Kornitzer JM, Kimura Y, Janow GL. Primary Sjogren syndrome in a child with a Neuromyelitis Optica Spectrum disorder. J Rheumatol. 2016;43:1260–1.PubMedCrossRef
4.
Arabshahi B. Devic disease in a child with primary Sjogren syndrome. J Child Neurol. 2006;21:284–6.PubMedCrossRef
5.
Bogdanovic R, Basta-Jovanovic G, Putnik J, Stajic N, Paripovic A. Renal involvement in primary Sjogren syndrome of childhood: case report and literature review. Mod Rheumatol. 2013;23:182–9.PubMedCrossRef
6.
Kumon K, Satake A, Mizumoto M, Kobayashi I, Ishikawa N. A case of sensory neuropathy associated with childhood Sjogren syndrome. Eur J Pediatr. 2000;159:630–1.PubMedCrossRef
7.
Pessler F, Emery H, Dai L, Wu YM, Monash B, Cron RQ, Pradhan M. The spectrum of renal tubular acidosis in paediatric Sjogren syndrome. Rheumatology (Oxford). 2006;45:85–91.CrossRef
8.
Jung SK, Park KH, Yim HE, Yoo KH, Hong YS, Lee JW, Won NH. Primary Sjogren’s syndrome with mesangial proliferative glomerulonephritis and IgA deposits in a child. Pediatr Nephrol. 2010;25:567–8.PubMedCrossRef
9.
Igarashi T, Itoh Y, Shimizu A, Igarashi T, Yoshizaki K, Fukunaga Y. A case of juvenile Sjogren’s syndrome with interstitial nephritis. J Nippon Med Sch. 2012;79:286–90.PubMedCrossRef
10.
Gottfried JA, Finkel TH, Hunter JV, Carpentieri DF, Finkel RS. Central nervous system Sjogren’s syndrome in a child: case report and review of the literature. J Child Neurol. 2001;16:683–5.PubMedCrossRef
11.
Wong S, Pollock AN, Burnham JM, Sherry DD, Dlugos DJ. Acute cerebellar ataxia due to Sjogren syndrome. Neurology. 2004;62:2332–3.PubMedCrossRef
12.
Kagan M, Bervina N, Vorobyeva O, Wouters C, Levtchenko E. Pauci-immune crescentic glomerulonephritis complicating Sjogren’s syndrome in a 12-year-old girl. Pediatr Nephrol. 2011;26:991–2.PubMedCrossRef
13.
DeGuzman M, Fishman MA, Lewis RA, McCluggage C, Warren RW, Finegold MJ. Chronic neurologic disease with visual, gait, and bladder problems in a male teenager. J Pediatr. 1998;132:742–7.PubMedCrossRef
14.
Skalova S, Minxova L, Slezak R. Hypokalaemic paralysis revealing Sjogren’s syndrome in a 16-year old girl. Ghana Med J. 2008;42:124–8.PubMedPubMedCentral
15.
Yoshida K, Suzuki J, Kume K, Suzuki S, Isome M, Kato K, Suzuki H. Sjogren’s syndrome with membranous glomerulonephritis detected by urine screening of schoolchildren. Acta Paediatr Jpn. 1996;38:533–6.PubMedCrossRef
16.
Berman JL, Kashii S, Trachtman MS, Burde RM. Optic neuropathy and central nervous system disease secondary to Sjogren’s syndrome in a child. Ophthalmology. 1990;97:1606–9.PubMedCrossRef
17.
Zawadzki J. Permeability defect with bicarbonate leak as a mechanism of immune-related distal renal tubular acidosis. Am J Kidney Dis. 1998;31:527–32.PubMedCrossRef
18.
Kobayashi I, Furuta H, Tame A, Kawamura N, Kojima K, Endoh M, Okano M, Sakiyama Y. Complications of childhood Sjogren syndrome. Eur J Pediatr. 1996;155:890–4.PubMedCrossRef
19.
Chang YC, Huang CC, Chiou YY, Yu CY. Renal tubular acidosis complicated with hypokalemic periodic paralysis. Pediatr Neurol. 1995;13:52–4.PubMedCrossRef
20.
Ohlsson V, Strike H, James-Ellison M, Tizard EJ, Ramanan AV. Renal tubular acidosis, arthritis and autoantibodies: primary Sjogren’s syndrome in childhood. Rheumatology (Oxford). 2006;45:238–40.CrossRef
21.
Hoshina T, Yamaguchi Y, Ohga S, Kira R, Ishimura M, Takada H, Tanaka T, Hara T. Sjogren’s syndrome-associated meningoencephalomyelitis: cerebrospinal fluid cytokine levels and therapeutic utility of tacrolimus. J Neurol Sci. 2008;267:182–6.PubMedCrossRef
22.
Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD atlas of renal pathology: kidney disease in primary Sjogren syndrome. Am J Kidney Dis. 2017;69:e29–30.PubMedCrossRef
23.
Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, Hogan MC. Renal involvement in primary Sjogren’s syndrome: a clinicopathologic study. Clin J Am Soc Nephrol. 2009;4:1423–31.PubMedPubMedCentralCrossRef
24.
Goules AV, Tatouli IP, Moutsopoulos HM, Tzioufas AG. Clinically significant renal involvement in primary Sjogren’s syndrome: clinical presentation and outcome. Arthritis Rheum. 2013;65:2945–53.PubMedCrossRef
25.
Ramos-Casals M, Brito-Zeron P, Solans R, Camps MT, Casanovas A, Sopena B, Diaz-Lopez B, Rascon FJ, Qanneta R, Fraile G, et al. Systemic involvement in primary Sjogren’s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology (Oxford). 2014;53:321–31.CrossRef
26.
Yang HX, Wang J, Wen YB, Fei YY, Jiang MD, Zhou MY, Zhang W, Li H, Li XM, Zhang FC, et al. Renal involvement in primary Sjogren’s syndrome: a retrospective study of 103 biopsy-proven cases from a single center in China. Int J Rheum Dis. 2018;21:223–9.PubMedCrossRef
27.
Wang J, Wen Y, Zhou M, Shi X, Jiang L, Li M, Yu Y, Li X, Li X, Zhang W, et al. Ectopic germinal center and megalin defect in primary Sjogren syndrome with renal Fanconi syndrome. Arthritis Res Ther. 2017;19:120.PubMedPubMedCentralCrossRef
28.
Means C, Aldape MA, King E. Pediatric primary Sjogren syndrome presenting with bilateral ranulas: a case report and systematic review of the literature. Int J Pediatr Otorhinolaryngol. 2017;101:11–9.PubMedCrossRef
29.
Yokogawa N, Lieberman SM, Sherry DD, Vivino FB. Features of childhood Sjogren’s syndrome in comparison to adult Sjogren’s syndrome: considerations in establishing child-specific diagnostic criteria. Clin Exp Rheumatol. 2016;34:343–51.PubMed
30.
Teixeira F, Moreira I, Silva AM, Vasconcelos C, Farinha F, Santos E. Neurological involvement in primary Sjogren syndrome. Acta Reumatol Port. 2013;38:29–36.PubMed
31.
Morreale M, Marchione P, Giacomini P, Pontecorvo S, Marianetti M, Vento C, Tinelli E, Francia A. Neurological involvement in primary Sjogren syndrome: a focus on central nervous system. PLoS One. 2014;9:e84605.PubMedPubMedCentralCrossRef
32.
Moreira I, Teixeira F, Martins Silva A, Vasconcelos C, Farinha F, Santos E. Frequent involvement of central nervous system in primary Sjogren syndrome. Rheumatol Int. 2015;35:289–94.PubMedCrossRef
33.
Massara A, Bonazza S, Castellino G, Caniatti L, Trotta F, Borrelli M, Feggi L, Govoni M. Central nervous system involvement in Sjogren’s syndrome: unusual, but not unremarkable--clinical, serological characteristics and outcomes in a large cohort of Italian patients. Rheumatology (Oxford). 2010;49:1540–9.CrossRef
34.
Mellgren SI, Conn DL, Stevens JC, Dyck PJ. Peripheral neuropathy in primary Sjogren’s syndrome. Neurology. 1989;39:390–4.PubMedCrossRef
35.
Kaltreider HB, Talal N. The neuropathy of Sjogren’s syndrome. Trigeminal nerve involvement. Ann Intern Med. 1969;70:751–62.PubMedCrossRef
36.
Chai J, Logigian EL. Neurological manifestations of primary Sjogren’s syndrome. Curr Opin Neurol. 2010;23:509–13.PubMedCrossRef
37.
Gono T, Kawaguchi Y, Katsumata Y, Takagi K, Tochimoto A, Baba S, Okamoto Y, Ota Y, Yamanaka H. Clinical manifestations of neurological involvement in primary Sjogren’s syndrome. Clin Rheumatol. 2011;30:485–90.PubMedCrossRef
38.
Tobon GJ, Pers JO, Devauchelle-Pensec V, Youinou P. Neurological disorders in primary Sjogren’s syndrome. Autoimmune Dis. 2012;2012:645967.PubMedPubMedCentral
39.
Bakchine S, Duyckaerts C, Hassine L, Chaunu MP, Turell E, Wechsler B, Chain F. Central and peripheral neurologic lesions in primary Gougerot-Sjogren syndrome. Clinicopathological study of a case. Rev Neurol (Paris). 1991;147:368–75.
40.
Alexander EL, Ranzenbach MR, Kumar AJ, Kozachuk WE, Rosenbaum AE, Patronas N, Harley JB, Reichlin M. Anti-Ro (SS-A) autoantibodies in central nervous system disease associated with Sjogren’s syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurology. 1994;44:899–908.PubMedCrossRef
41.
Molina R, Provost TT, Alexander EL. Peripheral inflammatory vascular disease in Sjogren’s syndrome. Association with nervous system complications. Arthritis Rheum. 1985;28:1341–7.PubMedCrossRef
42.
lexander E, Provost TT. Sjogren’s syndrome. Association of cutaneous vasculitis with central nervous system disease. Arch Dermatol. 1987;123:801–10.PubMedCrossRef
43.
Alexander EL, Provost TT, Sanders ME, Frank MM, Joiner KA. Serum complement activation in central nervous system disease in Sjogren’s syndrome. Am J Med. 1988;85:513–8.PubMedCrossRef
44.
Francois H, Mariette X. Renal involvement in primary Sjogren syndrome. Nat Rev Nephrol. 2016;12:82–93.PubMedCrossRef
45.
Evans R, Zdebik A, Ciurtin C, Walsh SB. Renal involvement in primary Sjogren’s syndrome. Rheumatology (Oxford). 2015;54:1541–8.CrossRef
46.
Ren H, Wang WM, Chen XN, Zhang W, Pan XX, Wang XL, Lin Y, Zhang S, Chen N. Renal involvement and followup of 130 patients with primary Sjogren’s syndrome. J Rheumatol. 2008;35:278–84.PubMed
47.
Lin DF, Yan SM, Yan Z, Wen Z, Meng-Tao LI, Zeng XF, Zhang FC, Yi D. Clinical and prognostic characteristics of 573 cases of primary Sj(o)gren’s syndrome. J Chin Med. 2010;123:3252–7.
48.
Kidder D, Rutherford E, Kipgen D, Fleming S, Geddes C, Stewart GA. Kidney biopsy findings in primary Sjogren syndrome. Nephrol Dial Transplant. 2015;30:1363–9.PubMedCrossRef
49.
Chen PH, Yang YH, Lin YT, Lee JH, Wang LC, Yu HH, Chiang BL. Clinical characteristics of children with positive anti-SSA/SSB antibodies. Rheumatol Int. 2014;34:1123–7.PubMedCrossRef
50.
Virdee S, Greenan-Barrett J, Ciurtin C. A systematic review of primary Sjogren’s syndrome in male and paediatric populations. Clin Rheumatol. 2017;36:2225–36.PubMedPubMedCentralCrossRef
51.
Mofors J, Holmqvist M, Westermark L, Bjork A, Kvarnstrom M, Forsblad-d’Elia H, Magnusson Bucher S, Eriksson P, Theander E, Mandl T, et al. Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjogren’s syndrome. J Intern Med. 2019;286:458–68.PubMedPubMedCentralCrossRef
52.
Kang KY, Kim HO, Kwok SK, Ju JH, Park KS, Sun DI, Jhun JY, Oh HJ, Park SH, Kim HY. Impact of interleukin-21 in the pathogenesis of primary Sjogren’s syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands. Arthritis Res Ther. 2011;13:R179.PubMedPubMedCentralCrossRef
53.
Zhao Y, Li Y, Wang L, Li XF, Huang CB, Wang GC, Zhang XW, Zhang ZL, Zhang X, Xiao WG, et al. Primary Sjogren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients. Medicine (Baltimore). 2015;94:e667.CrossRef
54.
Berra A, Sterin-Borda L, Bacman S, Borda E. Role of salivary IgA in the pathogenesis of Sjogren syndrome. Clin Immunol. 2002;104:49–57.PubMedCrossRef
55.
Speight PM, Cruchley A, Williams DM. Quantification of plasma cells in labial salivary glands: increased expression of IgM in Sjogren’s syndrome. J Oral Pathol Med. 1990;19:126–30.PubMedCrossRef
56.
Horsfall AC, Rose LM, Maini RN. Autoantibody synthesis in salivary glands of Sjogren’s syndrome patients. J Autoimmun. 1989;2:559–68.PubMedCrossRef
57.
Schuetz C, Prieur AM, Quartier P. Sicca syndrome and salivary gland infiltration in children with autoimmune disorders: when can we diagnose Sjogren syndrome? Clin Exp Rheumatol. 2010;28:434–9.PubMed
Metadata
Title
Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature
Authors
Jingya Zhao
Qin Chen
Yunyun Zhu
Meng Zhao
Jun Liu
Zhenzhong Zhang
Xiaoting Gong
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2020
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-020-00431-y

Other articles of this Issue 1/2020

Pediatric Rheumatology 1/2020 Go to the issue

Research article

Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists

Research article

Patient and physician discordance of global disease assessment in juvenile dermatomyositis: findings from the Childhood Arthritis & Rheumatology Research Alliance Legacy Registry

Research article

Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

Case Report

Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype

Case Report

Leukoencephalopathy and cerebral edema as the presenting manifestations of SLE in an ANA-negative adolescent female: a case report and review of literature

Research article

Determinants of disease activity change over time in Enthesitis related arthritis: effect of structured outcome monitoring and clinical decision support